In addition, in this study we performed mass spectroscopy proteomic analysis in order to identify differentially expressed molecules involved in AD pathogenies, neurodegeneration, and repair; and test whether specific molecules and/or pathways were selectively reversed by ADAM17 re-expression. This evidence concerns the gene ADAM17 and Alzheimer disease.